Skip to main content

Moderna, Inc. balance sheet

  • MRNA · Nasdaq
  • Biotechnology
  • S&P 500
$223.37−3.45%Close 13 Nov 2026 · Market value $87.52B

At the end of fiscal 2025 (the year to 31 Dec 2025), Moderna, Inc. reported total assets of $12.34B, $2.60B in cash and equivalents, $670.0M of total debt; shareholders' equity was $8.65B.

From Moderna, Inc.'s annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025.

Annual

Moderna, Inc. balance sheet, annual
USDFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Cash and equivalents$50.08M$134.9M$658.4M$235.9M$2.62B$6.85B$3.21B$2.91B$1.93B$2.60B
Short-term investments—$621.2M$863.1M$867.1M$1.98B$3.88B$6.70B$5.70B$5.10B$3.20B
Cash and short-term investments$50.08M$756.0M$1.52B$1.10B$4.61B$10.73B$9.90B$8.60B$7.03B$5.80B
Accounts receivable—$11.88M$11.69M$5.37M$1.39B$3.17B$1.39B$892.0M$358.0M$184.0M
Inventory———$0.00$47.00M$1.44B$949.0M$202.0M$117.0M$153.0M
Current assets—$783.2M$1.56B$1.13B$6.30B$16.07B$13.43B$10.32B$8.10B$6.54B
Property, plant and equipment—$139.0M$212.0M———————
Goodwill——————$0.00$52.00M$52.00M$52.00M
Acquired intangibles——————$0.00$44.00M$40.00M$45.00M
Total assets—$1.08B$1.96B$1.59B$7.34B$24.67B$25.86B$18.43B$14.14B$12.34B
Accounts payable—$20.73M$31.21M$7.09M$18.00M$302.0M$487.0M$520.0M$405.0M$317.0M
Unearned revenue, current—$96.74M$109.1M$63.31M$3.87B$6.25B$2.04B$568.0M$153.0M$99.00M
Current liabilities—$191.5M$222.8M$143.1M$4.39B$9.13B$4.92B$3.02B$2.21B$1.99B
Long-term debt · non-current————————$0.00$590.0M
Operating lease liability———$97.26M$103.4M$152.0M$127.0M$668.0M$685.0M$670.0M
Finance lease liability———$38.69M$134.2M$764.0M$1.07B$575.0M$62.00M$45.00M
Total liabilities—$459.2M$431.9M$414.6M$4.78B$10.52B$6.74B$4.57B$3.24B$3.69B
Retained earnings—−$621.9M−$1.01B−$1.50B−$2.24B$9.96B$18.32B$13.61B$10.04B$7.22B
Shareholders' equity−$334.8M−$551.4M$1.53B$1.17B$2.56B$14.14B$19.12B$13.85B$10.90B$8.65B
Total liabilities and equity—$1.08B$1.96B$1.59B$7.34B$24.67B$25.86B$18.43B$14.14B$12.34B
Total debt——$0.00$135.9M$237.6M$916.0M$1.20B$1.24B$685.0M$670.0M
Net debt——−$1.52B−$967.1M−$4.37B−$9.81B−$8.70B−$7.36B−$6.34B−$5.13B
Net working capital—$456.9M$681.8M$749.8M−$715.0M$95.00M$5.30B$4.40B$3.97B$1.96B
Shares outstanding · period end—65.2M329M337M399M403M385M382M386M394M

Quarterly

Moderna, Inc. balance sheet, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Cash and equivalents$2.91B$2.05B$2.48B$1.64B$1.93B$1.62B$1.28B$1.13B$2.60B$1.91B$1.72B$1.20B
Short-term investments$5.70B$6.47B$6.01B$5.22B$5.10B$4.35B$3.85B$3.37B$3.20B$3.30B$3.42B$3.98B
Cash and short-term investments$8.60B$8.52B$8.49B$6.87B$7.03B$5.97B$5.13B$4.50B$5.80B$5.21B$5.14B$5.17B
Accounts receivable$892.0M$137.0M$163.0M$1.56B$358.0M$78.00M$36.00M$1.05B$184.0M$71.00M$17.00M$1.37B
Inventory$202.0M$295.0M$399.0M$412.0M$117.0M$128.0M$240.0M$332.0M$153.0M$146.0M$280.0M$313.0M
Current assets$10.32B$9.60B$9.66B$9.67B$8.10B$6.77B$6.17B$6.60B$6.54B$5.77B$5.82B$7.34B
Goodwill$52.00M$52.00M$52.00M$52.00M$52.00M$52.00M$52.00M$52.00M$52.00M$52.00M$52.00M$52.00M
Acquired intangibles$44.00M$43.00M$42.00M$41.00M$40.00M$49.00M$48.00M$47.00M$45.00M$116.0M$109.0M$102.0M
Total assets$18.43B$16.73B$15.68B$15.80B$14.14B$12.70B$12.01B$12.13B$12.34B$11.49B$10.96B$13.47B
Accounts payable$520.0M$183.0M$279.0M$373.0M$405.0M$226.0M$175.0M$267.0M$317.0M$161.0M$167.0M$259.0M
Unearned revenue, current$568.0M$559.0M$702.0M$379.0M$153.0M$125.0M$218.0M$163.0M$99.00M$102.0M$295.0M$268.0M
Current liabilities$3.02B$2.38B$2.36B$2.20B$2.21B$1.60B$1.57B$1.68B$1.99B$2.40B$2.53B$2.03B
Long-term debt · non-current————$0.00———$590.0M$590.0M$591.0M—
Operating lease liability$668.0M$662.0M$693.0M$700.0M$685.0M$682.0M$682.0M$677.0M$670.0M$664.0M$659.0M$653.0M
Finance lease liability$575.0M$575.0M$576.0M$655.0M$62.00M$63.00M$59.00M$57.00M$45.00M$44.00M$37.00M$27.00M
Total liabilities$4.57B$3.91B$3.97B$3.88B$3.24B$2.64B$2.61B$2.81B$3.69B$4.08B$4.20B$6.63B
Retained earnings$13.61B$12.43B$11.15B$11.16B$10.04B$9.07B$8.25B$8.05B$7.22B$5.88B$5.10B$5.26B
Shareholders' equity$13.85B$12.82B$11.71B$11.93B$10.90B$10.07B$9.40B$9.33B$8.65B$7.41B$6.76B$6.84B
Total liabilities and equity$18.43B$16.73B$15.68B$15.80B$14.14B$12.70B$12.01B$12.13B$12.34B$11.49B$10.96B$13.47B
Total debt$1.24B$1.24B$1.27B$1.35B$685.0M$745.0M$741.0M$734.0M$670.0M$1.25B$1.25B$3.61B
Net debt−$7.36B−$7.29B−$7.22B−$5.51B−$6.34B−$5.23B−$4.39B−$3.77B−$5.13B−$3.95B−$3.89B−$1.56B
Net working capital$4.40B$5.17B$4.82B$5.82B$3.97B$3.54B$3.32B$3.79B$1.96B$1.47B$1.56B$4.12B
Shares outstanding · period end382M383M384M385M386M387M389M391M394M397M399M404M

The main figures as JSON and plain text. See data and methodology.

MRNA in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.